Generalized Myasthenia Gravis Market Expected to Reach USD 15.6 Billion by 2036

Generalized Myasthenia Gravis Market Expected to Reach USD 15.6 Billion by 2036

DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on the Generalized Myasthenia Gravis (gMG) market providing insights into the drug market landscape and market forecast

Read More

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Synovial Sarcoma Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the Synovial Sarcoma pipeline drug profiles,

Read More

Autistic Disorder Clinical Trial Pipeline Gains Momentum: 25+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Autistic Disorder Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Autistic Disorder pipeline landscape. It covers the Autistic Disorder pipeline drug

Read More

Atopic Dermatitis Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharma, SCM Lifescience, Sun Pharma

The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB

Read More

Bipolar Depression Market Poised for Robust Growth with Upcoming Novel Therapies and Improved Diagnostics

DelveInsight, a prominent market research company, has announced the publication of its latest report titled “Bipolar Depression Market Insights, Epidemiology, and Market Forecast 2036.” The Bipolar Depression report offers a

Read More

Inflammatory Bowel Disease Market to Undergo Major Transformation Through 2036 Fueled by Advanced Biologics, Precision Therapies, and Expanding Patient Population | DelveInsight

The BD market is witnessing remarkable growth driven by the increasing prevalence of Crohn’s disease and ulcerative colitis, rising adoption of advanced biologics and targeted therapies, growing awareness regarding early

Read More

Autosomal Dominant Polycystic Kidney Disease Market Set for Significant Expansion Through 2036 Driven by Rising Disease Burden and Emerging Disease-Modifying Therapies | DelveInsight

The ADPKD market is witnessing substantial growth driven by increasing diagnosed patient populations, advancements in genetic testing and diagnostic technologies, rising awareness regarding chronic kidney diseases, and growing adoption of

Read More

Osteoporosis Market to Witness Transformational Growth Through 2036 Driven by Rising Disease Burden and Emerging Bone-Building Therapies | DelveInsight

The Osteoporosis market is experiencing substantial growth driven by the increasing aging population, rising prevalence of fragility fractures, growing awareness regarding bone health, and expanding adoption of advanced anabolic and

Read More

Glioblastoma Multiforme Market to Witness Transformational Growth Opportunities by 2036 – DelveInsight | AstraZeneca, DNAtrix, Chimerix, Northwest Therapeutics, Bayer, Kazia Therapeutics, Aivita Bio

The Key Glioblastoma Multiforme Companies in the market include – Bayer, VBL Therapeutics, AstraZeneca, DNAtrix,Kintara Pharmaceuticals, Chimerix, KaryoPharma, VBI Vaccines, Kazia Therapeutics, AivitaBiomedical, Medicenna Therapeutics, Immunomic Therapeutics, Treovir, Istari Oncology,Inovio

Read More

Rett Syndrome Pipeline Gains Momentum as 20+ Leading Pharma Companies Advance Novel Therapies Through Expanding Clinical Trials | DelveInsight

DelveInsight’s, “Rett Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Rett Syndrome pipeline landscape. It covers the Rett Syndrome pipeline drug profiles,

Read More